WWA
RXRX icon

WCG Wealth Advisors’s Recursion Pharmaceuticals RXRX Stock Holding History

WCG Wealth Advisors’s Portfolio RXRX Stock Details RXRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$270K Buy
+73,524
New +$245K 0.01% 541
2026
Q1 		– Sell
-60,465
Closed -$247K – 540
2025
Q4 		$247K Buy
+60,465
New +$299K 0.01% 497

Other funds holding RXRX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
ARK Investment Management
ARK Investment Management St. Petersburg, Florida $15.4B AUM 50.29% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
SoftBank Group
SoftBank Group Tokyo, Japan $18.2B AUM 177.65% 1-Year Est. Return
MCMU
MIC Capital Management (UK) London, United Kingdom $394M AUM 25.64% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WCG Wealth Advisors's RXRX Position: Q2 2026 in Review

WCG Wealth Advisors opened a new position in Recursion Pharmaceuticals (RXRX) in Q2 2026: 73,524 shares worth $270K. The stake represents 0.01% of the portfolio and ranks #541 among its holdings. This is a return to the name: WCG Wealth Advisors previously reported a position in RXRX as recently as Q4 2025.

WCG Wealth Advisors first reported a position in RXRX in Q4 2025 and has held it in 2 quarters since. 343 funds tracked by Wall St. Rank hold RXRX as of Q2 2026.

  • WCG Wealth Advisors held 73,524 shares of Recursion Pharmaceuticals worth $270K as of Q2 2026.
  • Recursion Pharmaceuticals was a new WCG Wealth Advisors position in Q2 2026.
  • Recursion Pharmaceuticals made up 0.01% of WCG Wealth Advisors's portfolio in Q2 2026, its #541 holding.
  • WCG Wealth Advisors first reported a position in Recursion Pharmaceuticals in Q4 2025 and has held it in 2 quarters since.
  • 343 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q2 2026.

Based on WCG Wealth Advisors's 13F filing for Q2 2026, filed 14 Aug 2026.